bictegravir,
GS-9883,
Bictegravir,
GS-9883,
1611493-60-7,
UNII-8GB79LOJ07,
8GB79LOJ07,
GS-9883-01,
(2R,5S,13aR)-8-hydroxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide,
Bictegravir [INN],
Bictegravir [USAN:INN],
GS 9883,
Bictegravir (USAN/INN),
CHEMBL3989866,
SCHEMBL15914278,
SOLUWJRYJLAZCX-LYOVBCGYSA-N,
BCP25703,
AKOS032954062,
DB11799,
SB18851,
2,5-Methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxamide, 2,3,4,5,7,9,13,13a-octahydro-8-hydroxy-7,9-dioxo-N-((2,4,6-trifluorophenyl)methyl)-, (2R,5S,13aR)-,
HY-17605,
CS-0014685,
D10909,
Bictegravir sodium,
C21-H18-F3-N3-O5,
hydroxy-dioxo-N-[(2,4,6-trifluorophenyl)methyl][?]carboxamide,
(2R,5S,13aR)-7,9-dioxo-10-[(2,4,6-trifluorobenzyl carbamoyl]-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate,
BIC,